OverviewSuggest Edit

LeMaitre Vascular is a provider of devices and implants for the treatment of peripheral vascular disease. The company develops, manufactures, and markets disposable and implantable vascular devices to address the needs of vascular surgeons. It offers brand name devices used in arteries and veins outside of the heart.

TypePublic
Founded1983
HQBurlington, MA, US
Websitelemaitre.com
Employee Ratings2.7
Overall CultureC+

Latest Updates

Employees (est.) (Dec 2019)454
Job Openings29
Revenue (FY, 2020)$129.4 M(+11%)
Share Price (Nov 2021)$54.5
Cybersecurity ratingBMore
Discover new suppliers and conduct deeper comparison analysis with Craft for EnterpriseLearn more
Banner background

Key People/Management at LeMaitre Vascular

George W. Lemaitre

George W. Lemaitre

Chairman and Chief Executive Officer
David B. Roberts

David B. Roberts

President, Board Director
Laurie A. Churchill

Laurie A. Churchill

Senior Vice President & General Counsel
Kimberly L. Cieslak

Kimberly L. Cieslak

Vice President, Marketing
Ryan H. Connelly

Ryan H. Connelly

Vice President, Research & Development
Andrew Hodgkinson

Andrew Hodgkinson

Senior Vice President, Clinical, Regulatory & Quality Affairs
Show more

LeMaitre Vascular Office Locations

LeMaitre Vascular has offices in Burlington, North Brunswick Township, Kensington, Vaughan and in 9 other locations
Burlington, MA, US (HQ)
63 Second Ave
North Brunswick Township, NJ, US
206 N Center Dr
Kensington, AU
49 Stubbs St
Vaughan, CA
9135 Keele St, Suite B6
Shanghai, CN
809, 407 Yishan Rd, Xuhui Qu
Saint-Étienne, FR
28 Rue de la Télématique
Show all (13)

LeMaitre Vascular Financials and Metrics

LeMaitre Vascular Revenue

Embed Graph
View revenue for all periods
LeMaitre Vascular's revenue was reported to be $129.37 m in FY, 2020
USD

Revenue (Q1, 2021)

35.9m

Gross profit (Q1, 2021)

23.8m

Gross profit margin (Q1, 2021), %

66.3%

Net income (Q1, 2021)

5.9m

EBIT (Q1, 2021)

7.9m

Market capitalization (12-Nov-2021)

1.2b

Closing stock price (12-Nov-2021)

54.5

Cash (31-Mar-2021)

23.5m

EV

1.2b
LeMaitre Vascular's current market capitalization is $1.2 b.
Annual
USDFY, 2017FY, 2018FY, 2019FY, 2020

Revenue

100.9m105.6m117.2m129.4m

Revenue growth, %

5%11%

Cost of goods sold

30.2m31.6m37.4m44.7m

Gross profit

70.7m73.9m79.9m84.6m
Quarterly
USDQ1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019Q3, 2019Q1, 2020Q2, 2020Q3, 2020Q1, 2021

Revenue

24.1m25.8m24.8m26.0m27.0m24.2m28.5m29.5m29.1m30.6m24.9m36.4m35.9m

Cost of goods sold

6.8m8.2m7.2m7.5m8.0m6.9m9.0m9.2m8.9m10.1m7.8m13.7m12.1m

Gross profit

17.4m17.5m17.6m18.5m19.0m17.3m19.5m20.3m20.2m20.5m17.0m22.7m23.8m

Gross profit Margin, %

72%68%71%71%70%71%68%69%69%67%69%62%66%
Annual
USDFY, 2017FY, 2018FY, 2019FY, 2020

Cash

19.1m26.3m11.8m26.8m

Accounts Receivable

15.0m15.7m16.6m19.6m

Prepaid Expenses

2.6m2.9m3.3m2.6m

Inventories

21.0m27.4m39.5m
Quarterly
USDQ1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019Q3, 2019Q1, 2020Q2, 2020Q3, 2020Q1, 2021

Cash

25.8m30.1m37.5m22.8m19.6m20.1m14.8m13.3m11.7m10.9m20.0m29.3m23.5m

Accounts Receivable

14.1m14.6m13.6m14.5m15.2m13.0m15.5m15.5m14.9m16.6m17.7m19.6m20.1m

Prepaid Expenses

2.0m2.9m3.5m2.3m2.5m4.3m3.1m2.1m3.2m1.9m2.8m2.6m1.7m

Inventories

20.6m20.5m21.1m21.8m21.7m23.9m29.4m32.2m36.7m40.6m
Annual
USDFY, 2017FY, 2018FY, 2019FY, 2020

Net Income

17.2m22.9m17.9m21.2m

Depreciation and Amortization

4.1m4.3m5.4m8.4m

Inventories

(1.4m)(4.3m)(11.3m)

Accounts Payable

1.5m4.3m(596.0k)4.3m
Quarterly
USDQ1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019Q3, 2019Q1, 2020Q2, 2020Q3, 2020Q1, 2021

Net Income

3.2m7.9m12.9m3.9m12.6m16.9m3.5m8.1m13.3m3.2m6.7m14.2m5.9m

Depreciation and Amortization

979.0k2.0m3.0m1.0m2.1m3.1m1.3m2.6m4.0m1.5m3.2m5.9m2.6m

Inventories

(1.1m)(767.0k)(1.3m)(808.0k)(1.3m)(3.1m)(2.4m)(5.3m)(9.6m)(1.9m)

Accounts Payable

(367.0k)(550.0k)787.0k(2.1m)(82.0k)(345.0k)(3.5m)(4.1m)(2.0m)(3.3m)(2.1m)1.9m(3.0m)
USDQ1, 2017

Financial Leverage

1.2 x
Show all financial metrics

LeMaitre Vascular Operating Metrics

FY, 2017FY, 2018FY, 2019

Facilities

1322

Facilities Owned Internationally, square feet

6.14 k12.96 k

Product Lines

151615

Sales Representatives

90108112
Show all operating metrics

LeMaitre Vascular Acquisitions / Subsidiaries

Company NameDateDeal Size
ArtegraftJune 22, 2020$90 m
CardioCelDecember 31, 2019
Tru-Incise (Eze-Sit) USDecember 31, 2019
VascuCelDecember 31, 2019
LeMaitre Cardial SASDecember 31, 2018
Syntel and PythonDecember 31, 2018
ProColDecember 31, 2016
RestoreFlowDecember 31, 2016
Restore Flow AllograftsNovember 10, 2016$14 m
Tru-Incise (Eze-Sit) OUSDecember 31, 2015
Show more

LeMaitre Vascular Revenue Breakdown

Embed Graph

LeMaitre Vascular revenue breakdown by business segment: 18.0% from Other Areas, 31.0% from Carotid Artery and 51.0% from Lower Extremities

LeMaitre Vascular revenue breakdown by geographic segment: 35.6% from Other Countries, 10.6% from Germany and 53.9% from United States

LeMaitre Vascular Cybersecurity Score

Cybersecurity ratingPremium dataset

B

87/100

SecurityScorecard logo

LeMaitre Vascular Environment, Social & Governance (ESG) Ratings

CSRHub ESG ratingPremium dataset

40-49

out of 100

CSRHub logo

LeMaitre Vascular Online and Social Media Presence

Embed Graph

LeMaitre Vascular Company Culture

  • Overall Culture

    C+

    68/100

  • CEO Rating

    D

    60/100

  • Compensation

    C+

    68/100

Learn more on Comparably

LeMaitre Vascular News and Updates

LeMaitre Vascular Will Announce Fourth Quarter 2020 Earnings Results on February 25, 2021

BURLINGTON, Mass., Jan. 27, 2021 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it will release its fourth quarter 2020 financial results on Thursday, February 25, 2021, after the market close. The company has scheduled a conference call for 5:00 PM ET the same day …

LeMaitre Vascular Acquires Cardial Business of BD

BURLINGTON, Mass., Oct. 24, 2018 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT), announced today that it has acquired the assets of Cardial, a subsidiary of BD (Becton, Dickinson & Company), located in Saint-Étienne, France. The total purchase price for the acquired assets was €2.0 …

LeMaitre Vascular Acquires Clot Management Business from Applied Medical

BURLINGTON, Mass., Sept. 26, 2018 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it has acquired the vascular clot management business of Applied Medical Resources Corporation for $14.2 million, of which $11.0 million was paid at closing and $3.2 million will be pai…

LeMaitre Vascular Blogs

LeMaitre to Participate at Upcoming Investor Conferences

BURLINGTON, Mass. , Nov. 02, 2021 (GLOBE NEWSWIRE) -- LeMaitre Vascular , Inc. (Nasdaq:LMAT) announced today that management will be participating in three upcoming virtual investor conferences. Stifel 2021 Virtual Healthcare Conference Monday, November 15, 2021 David Roberts , President, will

LeMaitre Will Announce Third Quarter 2021 Earnings Results on October 28, 2021

LeMaitre Will Announce Third Quarter 2021 Earnings Results on October 28, 2021 Content Import Thu, 10/14/2021 - 16:11 LeMaitre Will Announce Third Quarter 2021 Earnings Results on October 28, 2021 October 14, 2021 at 4:10 PM EDT This release is a backfill from…

LeMaitre Vascular to Participate at Upcoming Investor Conferences in September

BURLINGTON, Mass. , Sept. 01, 2021 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that management will be participating in four virtual investor conferences in September. Barrington Research 14 th Annual Virtual Fall Investment Conference Thursday, September 9, 2021

LeMaitre Vascular Announces Proposed Public Offering of Common Stock

BURLINGTON, Mass. , July 13, 2021 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT), a provider of peripheral vascular devices, implants and services, today announced that it has commenced an underwritten public offering of shares of its common stock.

LeMaitre Vascular Will Announce Third Quarter 2020 Earnings Results on October 29, 2020

BURLINGTON, Mass. , Oct. 09, 2020 (GLOBE NEWSWIRE) -- LeMaitre Vascular , Inc. (Nasdaq:LMAT) announced today that it will release its third quarter 2020 financial results on Thursday, October 29, 2020, after the market close. The company has scheduled a conference call for 5:00 PM EDT the same day

LeMaitre Vascular Announces Q2 2020 Financial Results

LeMaitre Vascular Announces Q2 2020 Financial Results Content Import Thu, 07/23/2020 - 16:25 LeMaitre Vascular Announces Q2 2020 Financial Results July 23, 2020 at 4:25 PM EDT This release is a backfill from a News Wire Earnings BURLI…
Show more

LeMaitre Vascular Frequently Asked Questions

  • When was LeMaitre Vascular founded?

    LeMaitre Vascular was founded in 1983.

  • Who are LeMaitre Vascular key executives?

    LeMaitre Vascular's key executives are George W. Lemaitre, David B. Roberts and Laurie A. Churchill.

  • How many employees does LeMaitre Vascular have?

    LeMaitre Vascular has 454 employees.

  • What is LeMaitre Vascular revenue?

    Latest LeMaitre Vascular annual revenue is $129.4 m.

  • What is LeMaitre Vascular revenue per employee?

    Latest LeMaitre Vascular revenue per employee is $284.9 k.

  • Who are LeMaitre Vascular competitors?

    Competitors of LeMaitre Vascular include Baxter International, Boston Scientific and Edwards Lifesciences.

  • Where is LeMaitre Vascular headquarters?

    LeMaitre Vascular headquarters is located at 63 Second Ave, Burlington.

  • Where are LeMaitre Vascular offices?

    LeMaitre Vascular has offices in Burlington, North Brunswick Township, Kensington, Vaughan and in 9 other locations.

  • How many offices does LeMaitre Vascular have?

    LeMaitre Vascular has 13 offices.